Stock Events

Stock Events

Search...

Corvus Pharmaceuticals (CRVS) Q2 2024 Earnings

6MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.14

-0.13

-0.13

-0.12

Details

Expected EPS

-0.135

Actual EPS

-0.12

Surprise EPS

0.02

Surprise Percent

+11.11%

Description

Corvus Pharmaceuticals (CRVS) has reported earnings of -0.12 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.